NCT03841396View on ClinicalTrials.gov

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 2, 2016

Primary Completion Date

July 15, 2016

Study Completion Date

July 15, 2016

Conditions
Injection Site Reaction
Interventions
DRUG

Sodium chloride

All participants received a single dose of sodium chloride as placebo

All Listed Sponsors
lead

Aspen Global Incorporated

INDUSTRY

NCT03841396 - A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. | Biotech Hunter | Biotech Hunter